Paid Clinical Trials in Huntsville, AL
As of September 2026, 90 paid clinical trials are recruiting in Huntsville, Alabama. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Huntsville offers studies at sites including Clearview Cancer Institute for conditions such as Major Depressive Disorder, Obesity, Coronary Artery Disease, Carcinoma, Non-Small-Cell Lung. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Huntsville
Trials by drug in Huntsville
Filter results
Newly added in Huntsville
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
84 clinical trials
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Tracking Results of Ablations to Combat AF Registry Generation 2
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Prevail Global Study
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Continuous Dual Aspiration Technique With Zoom System for Stroke
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Top Research Study Locations in Huntsville
Researchers run research studies in Huntsville, AL at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Clearview Cancer Institute | Carcinoma, Non-Small-Cell Lung, Prostate Cancer, Cancer of the Prostate | 11 |
| Heart Center Research LLC | Obesity, Atherosclerotic Cardiovascular Disease, Cardiovascular Disease | 7 |
| Heart Center Research, LLC | Atherosclerosis, Acute Myocardial Infarction, Cardiovascular Disease | 6 |
| Huntsville Hospital | Acute Stroke, Arterial Thromboembolism, Atrial Fibrillation | 5 |
| Rehabilitation & Neurological Services | Alzheimer Disease, Migraine, Episodic Migraine | 5 |
| Apogee Clinical Research, LLC | Chronic Kidney Disease Requiring Chronic Dialysis, Diabetic Kidney Disease (DKD), End Stage Renal Disease on Dialysis | 3 |
| Nephrology Consultants, LLC | End Stage Kidney Disease, Proteinuric Kidney Disease, Proteinuric Kidney Diseases | 3 |
| Nutraceuticals Research Institute | Healthy Aging, Menopausal Hot Flashes, Menopausal Women | 3 |
| University of Alabama - Huntsville Regional Medical Campus | Agitation, Alzheimer Disease, Generalized Anxiety Disorder (GAD) | 3 |
| Clearview Cancer Institute (Crestwood) | Cancer of the Prostate, Carcinoma, Carcinoma, Non-Small-Cell Lung (NSCLC) | 2 |
| Neurocrine Clinical Site | Major Depressive Disorder | 2 |
| UAB Huntsville Regional Medical Campus | Major Depressive Disorder, Depression, Depression and Suicide | 2 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| AES - DRS - Optimal Research Alabama - Huntsville | Type II Diabetes Mellitus | 1 |
| AURORA-1 Clinical Site | Chronic Weight Management, Obesity, Overweight | 1 |
| AURORA-2 Clinical Site | Chronic Weight Management, Obesity, Overweight | 1 |
| Apogee Clinical Research | Focal Segmental Glomerulosclerosis | 1 |
| Clearview Cancer Institute - Huntsville - Cci Drive | Colorectal Cancer | 1 |
| Clinic for Neurology | Epilepsy, Focal Epilepsy, Focal Seizure | 1 |
| Heart Center LLC, Huntsville | Aortic Stenosis, Calcific, Aortic Valve Stenosis | 1 |
| Heart Center Research | Cardiac Disease | 1 |
| Huntsville Heart Center | Aortic Stenosis, Coronary Artery Disease, Coronary Stenosis | 1 |
| Huntsville Hospital Heart Center | Cardiovascular Diseases | 1 |
| Huntsville, AL Investigative | Acute Heart Failure, Heart Failure | 1 |
| Longwood Research LLC | ASCVD, Type2Diabetes | 1 |
Active & Upcoming Studies in Huntsville (2026)
Recruiting trials in Huntsville grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cardiovascular (16 active studies)
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event · Phase 2 · Eli Lilly and Company
- A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis · Phase 2 · Beijing Inno Medicine Co., Ltd.
Cancer & tumors (13 active studies)
- Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC · Phase 2 · Pfizer
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma · Phase 3 · Immuneering Corporation
Neurology & pain (11 active studies)
- Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures · Phase 3 · Rapport Therapeutics Inc.
- Continuous Dual Aspiration Technique With Zoom System for Stroke · Imperative Care, Inc.
Diabetes & metabolic (9 active studies)
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities · Phase 3 · Ascletis Pharma (China) Co., Limited
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes · Phase 3 · Ascletis Pharma (China) Co., Limited
Mental health & behavior (4 active studies)
- A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder · Phase 2 · AbbVie
- Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder · Phase 2 · AbbVie
HIV / STI (1 active study)
- Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention · University of Chicago
Common conditions studied in Huntsville
- Major Depressive Disorder (6 active studies)
- Obesity (5 active studies)
- Coronary Artery Disease (4 active studies)
- Carcinoma, Non-Small-Cell Lung (3 active studies)
- Cardiovascular Disease (3 active studies)
- Overweight (3 active studies)
Leading research sponsors in Huntsville
- AstraZeneca
- AbbVie
- Eli Lilly and Company
- Amgen
- Nutraceuticals Research Institute
Frequently asked questions
How many paid clinical trials are currently recruiting in Huntsville?
There are approximately 90 recruiting clinical trials in Huntsville, Alabama listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Huntsville pay participants?
Most recruiting trials in Huntsville compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Huntsville?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Huntsville?
The most common conditions under active study in Huntsville include Major Depressive Disorder (6), Obesity (5), Coronary Artery Disease (4), Carcinoma, Non-Small-Cell Lung (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Huntsville?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Huntsville on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Huntsville?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Huntsville?
Recruiting research sites in Huntsville include Clearview Cancer Institute, Heart Center Research LLC, Heart Center Research, LLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Huntsville right now?
The largest active categories in Huntsville are Cardiovascular (16), Cancer & tumors (13), Neurology & pain (11). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.